Researchers from Children's Hospital of Philadelphia (CHOP) have discovered the underlying biology that identifies a subset ...

TUESDAY, Dec. 3, 2024 (HealthDay News) -- A newly approved immunotherapy can help adults with a difficult-to-treat form of ...

In a recent study published in Nature Cancer, researchers explore treatment resistance and relapse in T-cell acute ...

An expert highlighted unmet needs in treating T-cell acute lymphoblastic leukemia and where research may focus in the future.

Researchers have discovered the underlying biology that identifies a subset of patients with acute lymphoblastic leukemia who ...

A novel CAR T-cell therapy has benefitted patients with relapsed acute lymphoblastic leukemia, showing high response rates in ...

Immunotherapies have shaped the cancer research space over the past decade, proving effective for the treatment of some ...

ALL, certain drugs work for some patients who relapse, but these drugs are not effective for all patients who relapse.

By Vijay Kumar Malesu Phase 1b–2 trial evaluates the potential of CAR T-cell therapy obe-cel in relapsed or refractory B-cell ...

The FDA has granted fast track designation to LBS-007 for the treatment of patients with acute myeloid leukemia.

DelveInsight's “Hairy Cell Leukemia Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth ...